<< New report on global prostate cancer therapeutics market | Researchers devise new tools for typing cells from children with acute lymphatic leukemia >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Ergoresearch announces first quarter 2010 financial results

Published on November 28, 2009 at 12:42 AM · No Comments

Ergoresearch Ltd (TSX VENTURE:ERG) -

- Annual sales increased by 160% to $1 596 107 compared to $612 127 for the same period last year.

- Net profits before income tax of $187 169 representing an increase of 199% from $62 590 for the same period last year.

- Cash flow from operating activities significantly increased from $8 491 for the same period last year to $292 404 for the first quarter of 2010.

- Revenues for the past twelve months totalled $6 292 688 and net earnings for the same period totalled $835 289

All amounts in Canadian dollars unless otherwise stated.

Ergoresearch ltd ("Ergoresearch" or the "Company") announced today its results for the first quarter of 2010 ended September 30, 2009. During the year, Ergoresearch recorded unprecedented sales and a strong growth in net earnings and cash generated from operating activities.

During the first quarter ended September 30, 2009, the Company's sales reached $1 569 107, representing a 160% increase compared to the 2008 results then at $612 127. Net earnings before income taxes almost tripled from $62 590 for the same period last year to $187 169 this quarter.

Before the change in operating working capital, cash flow from operating activities significantly increased to $292 404 for the first quarter of 2010 compared to a $8 491 for the same period last year.

"We are satisfied with the results of this first quarter of 2010. Notwithstanding challenging economic times, the Company very successfully integrated its most recent acquisition while reaping the benefits of a strong internal growth in its other divisions. The first quarter will also mark history as the Company recorded yet another increase of its net profits not to mention generating positive cash flow from its operations and a strong growth in revenues.

"Such noteworthy improvements stand witness to the hard work of our employees, management team and Directors. All have rallied around a common strategy and provided their best efforts to allow the Company to reach summiting performances" stated Sylvain Boucher, President and CEO of Ergoresearch Ltd.

Source: Ergoresearch Ltd

Posted in:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading